Your browser doesn't support javascript.
loading
Mid-term trends and recent birth-cohort-dependent changes in incidence rates of cutaneous malignant melanoma in Italy.
Bucchi, Lauro; Mancini, Silvia; Crocetti, Emanuele; Dal Maso, Luigino; Baldacchini, Flavia; Vattiato, Rosa; Giuliani, Orietta; Ravaioli, Alessandra; Caldarella, Adele; Carrozzi, Giuliano; Ferretti, Stefano; Filiberti, Rosa Angela; Fusco, Mario; Gatti, Luciana; Gili, Alessio; Magoni, Michele; Mangone, Lucia; Mazzoleni, Guido; Michiara, Maria; Panato, Chiara; Piffer, Silvano; Piras, Daniela; Rosso, Stefano; Rugge, Massimo; Scala, Umberto; Tagliabue, Giovanna; Tumino, Rosario; Stanganelli, Ignazio; Falcini, Fabio.
Afiliação
  • Bucchi L; Romagna Cancer Registry, Romagna Cancer Institute, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forlì, Italy.
  • Mancini S; Romagna Cancer Registry, Romagna Cancer Institute, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forlì, Italy.
  • Crocetti E; Romagna Cancer Registry, Romagna Cancer Institute, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forlì, Italy.
  • Dal Maso L; Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.
  • Baldacchini F; Romagna Cancer Registry, Romagna Cancer Institute, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forlì, Italy.
  • Vattiato R; Romagna Cancer Registry, Romagna Cancer Institute, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forlì, Italy.
  • Giuliani O; Romagna Cancer Registry, Romagna Cancer Institute, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forlì, Italy.
  • Ravaioli A; Romagna Cancer Registry, Romagna Cancer Institute, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forlì, Italy.
  • Caldarella A; Tuscany Cancer Registry, Clinical and Descriptive Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.
  • Carrozzi G; Modena Cancer Registry, Public Health Department, Local Health Authority, Modena, Italy.
  • Ferretti S; Romagna Cancer Registry, section of Ferrara, Local Health Authority, and University of Ferrara, Ferrara, Italy.
  • Filiberti RA; Liguria Cancer Registry, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Fusco M; Napoli 3 Sud Cancer Registry, Naples, Italy.
  • Gatti L; Mantova Cancer Registry, Epidemiology Unit, Agenzia di Tutela della Salute (ATS) della Val Padana, Mantova, Italy.
  • Gili A; Department of Experimental Medicine, University of Perugia, Perugia, Italy.
  • Magoni M; Registry of Brescia Province, Epidemiology Unit, Brescia Health Protection Agency, Brescia, Italy.
  • Mangone L; Epidemiology Unit, Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Reggio Emilia, Italy.
  • Mazzoleni G; South Tyrol Tumour Registry, Bolzano, Italy.
  • Michiara M; Parma Cancer Registry, Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
  • Panato C; Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.
  • Piffer S; Trento Province Cancer Registry, Unit of Clinical Epidemiology, Trento, Italy.
  • Piras D; Sassari Cancer Registry, Azienda Regionale per la Tutela della Salute - ATS, Sassari, Italy.
  • Rosso S; Piedmont Cancer Registry, A.O.U. Città della Salute e della Scienza di Torino, Turin, Italy.
  • Rugge M; Veneto Tumour Registry, Azienda Zero, Padova, Italy.
  • Scala U; Cancer Registry - ASL Salerno, Salerno, Italy.
  • Tagliabue G; Lombardy Cancer Registry-Varese Province, Cancer Registry Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Tumino R; Cancer Registry and Histopathology Department, Provincial Health Authority (ASP), Ragusa, Italy.
  • Stanganelli I; Skin Cancer Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forlì, Italy.
  • Falcini F; Department of Dermatology, University of Parma, Parma, Italy.
Int J Cancer ; 148(4): 835-844, 2021 02 15.
Article em En | MEDLINE | ID: mdl-33405292
ABSTRACT
In Oceania, North America and north-western Europe, after decades of increase, cutaneous malignant melanoma (CMM) rates began to stabilise or decline before 2000. Anecdotal evidence suggests that the reversal of the incidence trend is extending to southern Europe. To obtain a formal confirmation, this nationwide study from Italy investigated the incidence trends by birth cohort. Twenty-one local cancer registries covering a population of 15 814 455 provided incidence data for primary CMM registered between 1994 and 2013. Trends in age-standardised rates were analysed using joinpoint regression models and age-period-cohort models. Age-standardised incidence showed a consistent increase throughout the period (estimated annual percent change, 3.6 [95% confidence interval, 3.2-4.0] among men and 2.5 [2.0-3.1] among women). This pattern was confirmed by a sensitivity analysis with removal of low-risk populations of southern Italy. The rates, however, showed a stabilisation or a decrease in men and women aged below 35. Using the cohort of 1949-the median cohort with respect to the number of cases for both genders-as a reference, the incidence rate ratio increased for successive cohorts born until 1973 (women) and 1975 (men), and subsequently tended to decline. For the most recent cohorts in both genders, the risk of disease returned to the level of the cohort of 1949. The changes observed in the latest generations can be interpreted as the earliest manifestations of a birth-cohort-dependent incidence decrease. Our study adds to previous data indicating that the reversal of the long-term upward incidence trend of CMM is extending to southern Europe.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Sistema de Registros / Medição de Risco / Melanoma Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Sistema de Registros / Medição de Risco / Melanoma Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article